CERECYTE PRESIDIO PC4182050-30Recalls & reported problems
Medos International Sàrl · PRESIDIO microcoil PRESIDIO 18 CERECYTE Coil 20mm x 50cm 190cm Contents: 1 Detachable Coil System · Class 2 · Implant
All models of CERECYTE PRESIDIO (16)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00878528003328), received between Dec 13, 2016 and Jan 13, 2017 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Premature Activation” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Premature Activation2
- Positioning Failure1
- Stretched1
Patient problems
- No Consequences Or Impact To Patient2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionJan 13, 2017Premature Activation; Stretched; Premature Activation; Stretched
AS REPORTED BY HEALTHCARE PROFESSIONAL, DURING THE COIL EMBOLIZATION OF AN ANEURYSM AT THE LEFT INTERNAL ILIAC ARTERY THE SHEATH INTRODUCER OF THREE COILS; CASHMERE COIL (CRC14102530/C31865), PRESIDIO COIL (PC418205030/C24507) AND ONE DELTAMAXX COIL (CDX18206030/C38424) SPLIT OPEN WHEN THE COILS WERE DELIVERED INTO THE CATHETER. THE PATIENT WAS AN (B)(6) MALE WHOSE VESSELS WERE HEAVILY TORTUROUS AND CALCIFICATION WAS UNKNOWN. AN APPROACH WAS TAKEN FROM THE LEFT FEMORAL ARTERY TO THE TARGET LESION. A COIL (CASHMERE, LOT UNKNOWN) WAS PLACED IN THE LESION AND THEN THE COMPLAINT CASHMERE COIL (LOT# C31865) WAS USED AS THE SECOND COIL. HOWEVER THE SHEATH SPLIT OPEN AT APPROXIMATELY 20CM FORM ITS PROXIMAL PORTION WHEN THE COIL WAS DELIVERED INTO THE MICRO CATHETER, AND IT COULD NOT BE DELIVERED AT ALL. THEREFORE A PRESIDIO COIL LOT# C24507 (COMPLAINT PRODUCT2) WAS DELIVERED TO THE LESION FOR THE 2ND COIL BUT AGAIN THE SHEATH SPLIT OPEN AT APPROXIMATELY 20CM FORM ITS PROXIMAL PORTION WHEN THE COIL WAS DELIVERED INTO THE MICRO CATHETER. THE COIL WAS CHANGED TO ANOTHER COIL (PRESIDIO, SAME SIZE) AND IT COULD BE PLACED IN THE LESION SUCCESSFULLY. AFTER WHICH, THE DELTAMAXX LOT# C38424 (COMPL
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6249174 ↗MalfunctionDec 13, 2016Positioning Failure; Premature Activation; Positioning Failure; Premature Activation
AS REPORTED BY A HEALTHCARE PROFESSIONAL, DURING COIL EMBOLIZATION OF A GASTRIC VEIN, A PRESIDIO COIL (PC4182050-30/C41671) FAILED TO DETACH, THE DELIVERY WIRE BECAME COMPRESSED AND THEN THE COIL PREMATURELY DETACHED IN THE NON-CODMAN MICROCATHETER DURING WITHDRAWAL. THE GUIDING CATHETER WAS APPROACHED TO THE LIENAL VEIN AND THE MICROCATHETER WAS ADVANCED TO THE POINT OF BACK-FLOW. THE EMBOLIZATION WAS STARTED. AFTER A PRESIDIO 18 COIL WAS USED SUCCESSFULLY, THE COMPLAINT PRESIDIO 18 WAS USED. THE EMBOLIZATION WAS COMPLETED AS USUAL. IT WAS CONFIRMED THAT THE POWER LIGHT WAS ILLUMINATED AND THE PHYSICIAN PRESSED THE DETACHMENT BUTTON. HOWEVER, THE COIL WAS NOT DEPLOYED WHEN THE DELIVERY WIRE WAS WITHDRAWN. THE COIL WAS REINSERTED AND THE BUTTON WAS PRESSED AGAIN IN THE STATE OF THE DELIVERY WIRE BEING COMPRESSED A LITTLE DUE TO PUSHING THE COIL SEVERAL TIMES. THIS PROCESS WAS REPEATED FOUR TIMES, BUT THE COIL WAS NOT DEPLOYED. THEREFORE, THE PHYSICIAN TRIED TO REMOVE THE COIL; HOWEVER, THE COIL WAS DEPLOYED WHEN IT WAS WITHDRAWN APPROXIMATELY 10 CM. IT WAS FLUSHED BY SALINE SOLUTION AND COIL COULD BE REMOVED FROM THE MICROCATHETER COMPLETELY. THE PROCEDURE WAS SUCCESSFULLY COMPLETE
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6169266 ↗
Other DEVICE, NEUROVASCULAR EMBOLIZATION devices
- POD RBYPODJ60-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION355 reports
- Penumbra System SCH1Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION295 reports
- RUBY Coil RBY4C0860-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION276 reports
- Smart Coil 400SMTHXSFT0208Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION165 reports
- Penumbra System RH1-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION154 reports
- Optima Coil System OPTI0208CSS10Balt USA LLC · Device, Neurovascular Embolization3 recalls3 reports
- POD RBYPOD6-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION148 reports
- POD RBYPODJ30-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION132 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page